Thais F. Conti

Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US

Nisha Malhotra, Tyler E. Greenlee, Amogh Iyer et al. · Ophthalmology · 2021 · 52 citations

Health Care Disparity, Ocular Disease, Cardiovascular Disease +6

Fluctuations in macular thickness in patients with diabetic macular oedema treated with anti-vascular endothelial growth factor agents

Victoria Y. Wang, Blanche L. Kuo, Andrew X. Chen et al. · Eye · 2021 · 30 citations · Full text

Diabetic Retinopathy, Ocular Disease, Cardiovascular Disease +9

CONSEQUENCES OF LAPSES IN TREATMENT WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE

Tyler E. Greenlee, Victoria Y. Wang, Hannah Kang et al. · Retina · 2020 · 25 citations

Fluctuations in Macular Thickness in Patients with Retinal Vein Occlusion Treated with Anti–Vascular Endothelial Growth Factor Agents

Andrew X. Chen, Tyler E. Greenlee, Thais F. Conti et al. · Ophthalmology Retina · 2020 · 24 citations

Ocular Disease, Ophthalmology, Cardiovascular Disease +6

Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis

Amy Babiuch, Thais F. Conti, Felipe F. Conti et al. · International Journal of Retina and Vitreous · 2019 · 21 citations · Full text